Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enhanced Early Soft-Tissue Healing With THERAVEX Technology

NCT: NCT07580599 · COMPLETED

NCT IDNCT07580599
StatusCOMPLETED
Start Date2024-12-03
Completion2026-01-01

Brief Summary

randomized, double-blind clinical trial aims to evaluate the effect of different postoperative mouthwashes on early soft-tissue healing following tooth extraction

Frequently Asked Questions

What is Enhanced Early Soft-Tissue Healing With THERAVEX Technology?

Enhanced Early Soft-Tissue Healing With THERAVEX Technology is a clinical trial registered under NCT07580599. Current status: COMPLETED.

What is the status of NCT07580599?

The current status of NCT07580599 (Enhanced Early Soft-Tissue Healing With THERAVEX Technology) is: COMPLETED.

When did Enhanced Early Soft-Tissue Healing With THERAVEX Technology start?

Enhanced Early Soft-Tissue Healing With THERAVEX Technology started on 2024-12-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑